Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN03397663
ISRCTN03397663
Completed
Not Applicable

Evaluation of the efficacy and safety of a Sheabutter extract on cold sores (herpes simplex labialis)

BSP Pharma A/S (Denmark)0 sites160 target enrollmentJuly 5, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHerpes Simplex LabialisSkin and Connective Tissue DiseasesHerpes simplex labialis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Herpes Simplex Labialis
Sponsor
BSP Pharma A/S (Denmark)
Enrollment
160
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 5, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
BSP Pharma A/S (Denmark)

Eligibility Criteria

Inclusion Criteria

  • •Subjects aged 18 and 75 years, in good general health who have a clinical history of recurrent herpes labialis, with at least six self reported episodes of herpes lesion in the past year and at least one recurrance every three months.

Exclusion Criteria

  • •1\. History of immunodeficiency
  • •2\. Use of other antiviral agents (including herbal medications), anti\-inflammatory medications, steroids or analgesics during the treatment period
  • •3\. Known allergy to Sheabutter
  • •4\. Liver function tests greater than 3 times the upper limit of normal at baseline
  • •5\. Female participants who are lactating, pregnant or planning to become pregnant
  • •6\. Participants who have participated in another clinical trial in the last 30 days
  • •7\. Participants unwilling to comply with the study protocol
  • •8\. Any other condition, which in the opinion of the investigators could compromise the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Prospective evaluation of efficacy and safety of argon plasma coagulation therapy with submucosal injection prior to ablation in Barrett's esophagusC15.5Lower third of oesophagus
DRKS00003369HSK Wiesbaden60
Not yet recruiting
Not Applicable
To know if the mouth wash prepared from certain herbal products is effective and safe to treat the gingivitisHealth Condition 1: A488- Other specified bacterial diseases
CTRI/2024/01/061413DR ZADC AMU ALIGARH
Active, not recruiting
Not Applicable
A study to determine the safety and efficacy of a terbinafine topical formulation system in subjects with onychomycosis in laser treated toenails versus ciclopirox lacquer in intact toenailsDistal/lateral Subungual onychomycosis (DSO) caused by dermatophytesMedDRA version: 8.1Level: LLTClassification code 10030338Term: Onychomycosis
EUCTR2006-005895-42-ISTLT Medical Ltd.235
Completed
Not Applicable
study on overall improvement of Skin Parameters
CTRI/2023/06/054242Transformative Learning Solutions Pvt Ltd75
Completed
Phase 1
A trial to evaluate an oral medicinal cannabis extract compared with placebo for the treatment of insomnia.InsomniaNeurological - Other neurological disorders
ACTRN12618000078257Zelda Therapeutics Limited24